The first ever clinical trial using neural stem cell therapy has begun with one patient in the UK, ReNeuron Group plc announced today. Known as the Pilot Investigation of Stem Cells in Stroke (PISCES) study, it is the first ever fully regulated neural stem cell therapy clinical trial for patients disabled by stroke. The company informs that stroke is the main cause of adult disability in industrial countries, and the third cause of death...
More...
More...